Literature DB >> 1505653

Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency.

S Muntoni1, B Batetta, S Dessi, S Muntoni1, P Pani.   

Abstract

Sardinian males with erythrocyte glucose-6-phosphate dehydrogenase (G-6-PD) deficiency have lower serum levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (ApoB), compared to normals. Since the enzyme deficiency is expressed also in nucleated cells, we studied cholesterol (C) and DNA synthesis and LDL-receptor expression in freshly isolated circulating mononuclear cells from normal and G-6-PD-deficient Sardinians. Synthesis of C (as 14C-acetate incorporation) and of DNA (as 3H-thymidine incorporation) was clearly reduced, both in basal state and after PHA stimulation, in G-6-PD-deficient cells compared to normal cells. On the other hand, no clear influence of G-6-PD deficiency on LDL-receptor expression could be demonstrated. The Mediterranean variant of G-6-PD deficiency is characterized, whatever the metabolic mechanism may be, by a serum lipoprotein pattern of reduced atherogenicity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505653     DOI: 10.1007/bf00145349

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  26 in total

1.  Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin.

Authors:  F C Hagemenas; D R Illingworth
Journal:  Arteriosclerosis       Date:  1989 May-Jun

2.  Hepatic glucose-6-phosphate dehydrogenase, cholesterogenesis, and serum lipoproteins in liver regeneration after partial hepatectomy.

Authors:  S Dessì; C Chiodino; B Batetta; A M Fadda; C Anchisi; P Pani
Journal:  Exp Mol Pathol       Date:  1986-04       Impact factor: 3.362

Review 3.  Variants of glucose-6-phosphate dehydrogenase.

Authors:  A G Motulsky; A Yoshida; G Stamatoyannopoulos
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

4.  Tissue enzyme levels in erythrocyte glucose-6-phosphate dehydrogenase deficiency.

Authors:  T K Chan; D Todd; C C Wong
Journal:  J Lab Clin Med       Date:  1965-12

Review 5.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

6.  Consensus conference. Lowering blood cholesterol to prevent heart disease.

Authors: 
Journal:  JAMA       Date:  1985-04-12       Impact factor: 56.272

7.  Cholesterol metabolism during ketoconazole treatment in man.

Authors:  T A Miettinen
Journal:  J Lipid Res       Date:  1988-01       Impact factor: 5.922

8.  Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.

Authors:  S M Grundy; D W Bilheimer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites.

Authors:  L Luzzatto; F A Usanga; S Reddy
Journal:  Science       Date:  1969-05-16       Impact factor: 47.728

10.  Hexose monophosphate shunt and cholesterol synthesis in the diabetic and fasting states.

Authors:  S Dessì; C Chiodino; B Batetta; E Laconi; C Ennas; P Pani
Journal:  Exp Mol Pathol       Date:  1985-10       Impact factor: 3.362

View more
  10 in total

1.  Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase.

Authors:  G Cappai; M Songini; A Doria; J D Cavallerano; M Lorenzi
Journal:  Diabetologia       Date:  2011-03-05       Impact factor: 10.122

2.  Cell growth and cholesterol metabolism in human glucose-6-phosphate dehydrogenase deficient lymphomononuclear cells.

Authors:  B Batetta; R R Bonatesta; F Sanna; M Putzolu; M F Mulas; M Collu; S Dessì
Journal:  Cell Prolif       Date:  2002-06       Impact factor: 6.831

Review 3.  Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.

Authors:  Peter A Hecker; Jane A Leopold; Sachin A Gupte; Fabio A Recchia; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

Review 4.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

Review 5.  Prevention of cardiovascular disease: from biomedical research to health policy.

Authors:  S Muntoni
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

6.  Hypocholesterolemia and nonregenerative, suspected immune-mediated, anemia: Report of 3 canine cases.

Authors:  Rachel Robbins; Katrina R Viviano
Journal:  Can Vet J       Date:  2017-10       Impact factor: 1.008

Review 7.  The Controversial Role of Glucose-6-Phosphate Dehydrogenase Deficiency on Cardiovascular Disease: A Narrative Review.

Authors:  Maria Pina Dore; Guido Parodi; Michele Portoghese; Giovanni Mario Pes
Journal:  Oxid Med Cell Longev       Date:  2021-04-29       Impact factor: 6.543

8.  The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease.

Authors:  Maria Pina Dore; Michele Portoghese; Giovanni Mario Pes
Journal:  J Atheroscler Thromb       Date:  2020-09-10       Impact factor: 4.928

Review 9.  Serum lipids and lipoproteins in malaria--a systematic review and meta-analysis.

Authors:  Benjamin J Visser; Rosanne W Wieten; Ingeborg M Nagel; Martin P Grobusch
Journal:  Malar J       Date:  2013-12-07       Impact factor: 2.979

10.  Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease.

Authors:  L Meloni; M R Manca; I Loddo; G Cioglia; P Cocco; A Schwartz; S Muntoni; Sa Muntoni
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.